Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
BMC Cancer, 05/24/2012Seidel C et al.
The report supports the notion that imatinib–induced hepatotoxicity may lead to acute liver damage with subsequent cirrhotic remodelling. Patients developing grade 3 or 4 hepatotoxicity during imatinib treatment should therefore be carefully evaluated for chronic liver disease.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.